Revenues, Recognition and Allowances (Tables)

6 Months Ended

Jun. 30, 2018

Revenue from Contract with Customer [Abstract]

Schedule of New Accounting Pronouncements and Changes in Accounting Principles

Disaggregation of Revenues

Net Sales (in thousands) for the three and six months ended June 30, 2018 and 2017 were as follows (prior-period amounts are not adjusted under the modified-retrospective method of adoption):

	Three months ended June 30,				Six months ended June 30,
	2018		2017		2018		2017
Company product sales	$	14,677	$	13,912	$	27,913	$	28,120
Contract manufacturing sales	1,450		2,407		2,748		5,824
Research and development services and other income	122		113		$	133	$	151
Revenue, net	$	16,249	$	16,432	$	30,794	$	34,095

Disaggregated information for the Company product sales revenue has been recognized in the accompanying unaudited interim Condensed Consolidated Statements of Operations is presented below according to contract type (in thousands):

	Three months ended June 30,				Six months ended June 30,
Company Product Sales	2018		2017		2018		2017
Topical	$	7,888	$	8,558	$	15,795	$	16,153
Injectables	6,789		5,354		12,118		11,967
Total	$	14,677	$	13,912	$	27,913	$	28,120

Schedule of Accounts, Notes, Loans and Financing Receivable

The Company's adjustments for the deductions to gross product sales are as follows (in thousands):

	Three months ended June 30,				Six months ended June 30,
	2018		2017		2018		2017
Gross product sales	$	48,142	$	66,744	$	84,690	$	121,044
Deduction to gross product sales:
Chargebacks and billbacks	21,449		44,090		38,364		74,105
Wholesaler fees for service	477		1,976		1,112		4,204
Sales discounts and other allowances	11,539		6,766		17,301		14,615
Total reduction to gross product sales	$	33,465	$	52,832	$	56,777	$	92,924
Company product sales, net	$	14,677	$	13,912	$	27,913	$	28,120